ELOVAC-B

ELOVAC-B
Product Description

Elovac-B (Recombinant Hepatitis - B vaccine) is a non infectious recombinant DNA vaccine. It is a sterile suspension of purified major surface antigen of Hepatitis B virus (HBV). Elovac-B Vaccine is indicated for immunization against infection caused by all known sub-types of Hepatitis B virus. Elovac-B is presented as a sterile ready to use slightly turbid white suspension for intra-muscular administration.  Elovac-B is marked as:-  0.5ml and 1ml single dose vial.5.0ml and 10.0ml Multi-dose Vial.

Indian Immunologicals Ltd

  • IN
  • 2019
    On CPhI since
Specifications

Indian Immunologicals Ltd

  • IN
  • 2019
    On CPhI since

More Products from Indian Immunologicals Ltd

  • ABHAYRAB

    Product ABHAYRAB

    Abhayrab is a purified Inactivated Rabies Vaccine prepared on Vero cells and is used for the prophylactic or post exposure immunization against Rabies. The vaccine is prepared using L.Pasteur 2061/Vero Rabies strain and is exported widely to 40 countries worldwide. Each pack consists of 1 dose vial along with Diluent Ampoule (0.5 ml), Sterile disposable syringe with needle and vaccination card. With IIL having the world's largest human rabies vaccine capacity, we can cater to the needs of our customers in any situation. 
  • RAKSHARAB

    Product RAKSHARAB

    Raksharab is recommended for immunization of dogs against rabies and contains inactivated rabies virus. The virus is propagated in BHK-21 Cell line, inactivated with an aziridine compound and concentrated. Single dose vial : 1 ml Multidose vial containing 5 doses : 5 ml Multidose vial containing 10 doses : 10 ml
  • Abhay-TOX

    Product Abhay-TOX

    Abhay - TOXTM Tetanus Vaccine (Adsorbed) manufactured by Human Biologicals Institute, for intramuscular injection, is a sterile suspension of Aluminium phosphate adsorbed tetanus toxoid in isotonic sodium chloride solution.

Indian Immunologicals Ltd resources

  • News COVID-19 VACCINE DEVELOPMENT

    Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

    Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.
  • News Spearheading one health initiative with the Government of India

    A fruitful meeting with Sh. Giriraj singh, Union minister of Animal husbandry, dairying and fisheries at Indian Immunologicals Limited, Gachibowli facility, Hyderabad.
  • News Controlling Rabies

    "Rabies causes an estimated 21,000 deaths in India each year, despite being completely vaccine preventable."

Recommended products